Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S339000, C514S414000, C514S235200, C544S144000, C546S277700, C548S465000, C548S509000
Reexamination Certificate
active
07109231
ABSTRACT:
A novel class of tricyclic compounds of the following formula (I): (formula I); is disclosed together with the use of such compounds for inhibiting sPLA2mediated release of fatty acids for treatment of inflammatory diseases such as septic shock
REFERENCES:
patent: 0 950 661 (1999-10-01), None
patent: WO 00 07591 (2000-02-01), None
D. J., Davies, “Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent ′b!indoles, tetrahydrocarbazoles and hexahydrocyclohept ′b!indoles,”J. Med. Chem., vol. 41, No. 4, pp. 451-467 (1998); XP002215114.
Kinnick Michael Dean
Mihelich Edward David
Morin, Jr. John Michael
Sall Daniel Jon
Sawyer Jason Scott
Eli Lilly and Company
Ginah Francis O.
Nolan Jason M.
LandOfFree
Cyclohept[b]indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclohept[b]indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohept[b]indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538803